Dietary supplementation with soybean lecithin increases pulmonary PAF bioactivity in asthmatic rats

Journal of Nutritional Biochemistry

Volumn 21, Issue 6, 2010, Pages 532-537

  Muehlmann, Luis A ^a   Zanatta, Ana L ^a   Farias, Carolina L A ^a   Bieberbach, Eloyse W ^a   Mazzonetto, Ana C ^a   Michellotto, Pedro V ^a   Fernandes, Luiz C ^a   Nishiyama, Anita ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Asthma; Lecithin; PAF like; Peroxidation; PUFA

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; GINKGOLIDE B; NITRIC OXIDE; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; THROMBOCYTE ACTIVATING FACTOR; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CALCIUM TRANSPORT; CAPILLARY PERMEABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; LIPID PEROXIDATION; LUNG CAPILLARY; MALE; NONHUMAN; PERMEABILITY BARRIER; POLYMORPHONUCLEAR CELL; RAT; RESPIRATORY TRACT INFLAMMATION; ANIMAL; ANIMAL FOOD; CHEMISTRY; CYTOLOGY; DISEASE MODEL; HORSE; LUNG LAVAGE; METABOLISM; NEUTROPHIL; SOYBEAN; WISTAR RAT;

ANIMAL FEED; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY ACIDS, UNSATURATED; HORSES; LECITHINS; LIPID PEROXIDATION; MALE; NEUTROPHILS; NITRIC OXIDE; RATS; RATS, WISTAR; SOYBEANS;

ANIMALIA; GLYCINE MAX; RATTUS; RATTUS NORVEGICUS;

EID: 77952881140     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.03.001     Document Type: Article

References (57)

1. Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nature Reviews Immunology 2006, 6:869-874.
2. Wills-Karp M., Santeliz J., Karp C.L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001, 1:69-75.
3. von Mutius E., Weiland S.K., Fritzsch C., et al. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. The Lancet 1998, 351:862-866.
4. Waite D.A., Eyles E.F., Tonkin S.L., et al. Asthma prevalence in Tokelauan children in two environments. Clin Exp Allergy 1980, 10:71-75.
5. Black P.N., Sharpe S. Dietary fat and asthma: is there a connection?. Eur Respir J 1997, 10:6-12.
6. Devereux G., Seaton A. Diet as a risk factor for atopy and asthma. J Allergy Clin Immunol 2005, 115:1109-1117.
7. Haby M.M., Peat J.K., Marks G.B., et al. Asthma in preschool children: prevalence and risk factors. Thorax 2001, 56:589-595.
8. Wijga A.H., Smit H.A., Kerkhof M., et al. Association of consumption of products containing milk fat with reduced asthma risk in pre-school children: the PIAMA birth cohort study. Thorax 2003, 58:567-572.
9. Bolte G., Frye C., Hoelscher B., et al. Margarine consumption and allergy in children. Am J Respir Crit Care Med 2001, 163:277-279.
10. Woods R.K., Walters E.H., Raven J.M., et al. Food and nutrient intakes and asthma risk in young adults. Am J Clin Nutr 2003, 78:414-421.
11. Buckingham K.W. Effect of dietary polyunsaturated/saturated fatty acid ratio and dietary vitamin E on lipid peroxidation in the rat. J Nutr 1985, 115:1425-1435.
12. Nagaraju A., Belur L.R. Rats fed blended oils containing coconut oil with groundnut oil or olive oil showed an enhanced activity of hepatic antioxidant enzymes and a reduction in LDL oxidation. Food Chem 2008, 108:950-957.
13. De Raeve H.R., Thunnissen F.B., Kaneko F.T., et al. Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. Am J Physiol 1997, 272:L148-L154.
14. Calhoun W.J., Reed H.E., Moest D.R., et al. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 1992, 145:317-325.
15. Hamid Q., Springall D.R., Riverosmoreno V., et al. Induction of nitric-oxide synthase in asthma. Lancet 1993, 342:1510-1513.
16. Wood L.G., Gibson P.G., Garg M.L. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 2003, 21:177-186.
17. Cracowski J.L., Durand T., Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci 2002, 23:360-366.
18. Zimmerman G.A., Prescott S.M., McIntyre T.M. Oxidatively fragmented phospholipids as inflammatory mediators - the dark side of polyunsaturated lipids. J Nutr 1995, 125:S1661-S1665.
19. Uhlig S., Goggel R., Engel S. Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung. Pharmacol Rep 2005, 57(Suppl):206-221.
20. Marathe G.K., Prescott S.M., Zimmerman G.A., et al. Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc Med 2001, 11:139-142.
21. Chung K.F. Platelet-activating factor in inflammation and pulmonary disorders. Clin Sci (Lond) 1992, 83:127-138.
22. Prescott S.M., Zimmerman G.A., Stafforini D.M., et al. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 2000, 69:419-445.
23. Zimmerman G.A., McIntyre T.M., Prescott S.M., et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 2002, 30:S294-S301.
24. Schuster M., Tschernig T., Krug N., et al. Lymphocytes migrate from the blood into the bronchoalveolar lavage and lung parenchyma in the asthma model of the brown Norway rat. Am J Respir Crit Care Med 2000, 161:558-566.
25. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
26. Bradford M.M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
27. Stuehr D.J., Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A 1985, 82:7738-7742.
28. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
29. Nourooz-Zadeh J., Tajaddini-Sarmadi J., Wolff S.P. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994, 220:403-409.
30. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450.
31. Talati M., Meyrick B., Peebles R.S., et al. Oxidant stress modulates murine allergic airway responses. Free Radic Biol Med 2006, 40:1210-1219.
32. Barnes P.J. Reactive oxygen species and airway inflammation. Free Radic Biol Med 1990, 9:235-243.
33. Frankel E.N. Lipid oxidation - mechanisms, products and biological significance. J Am Oil Chem Soc 1984, 61:1908-1917.
34. Spiteller G. Lipid peroxidation in aging and age-dependent diseases. Exp Gerontol 2001, 36:1425-1457.
35. Halliwell B., Gutteridge J.M.C. Biologically relevant metal ion-dependent hydroxyl radical generation - an update. FEBS Lett 1992, 307:108-112.
36. Berry E.M., Eisenberg S., Haratz D., et al. Effects of diets rich in monounsaturated fatty-acids on plasma-lipoproteins - the Jerusalem Nutrition Study - high MUFAs vs high PUFAs. Am J Clin Nutr 1991, 53:899-907.
37. Kratz M., Cullen P., Kannenberg F., et al. Effects of dietary fatty acids on the composition and oxidizability of low-density lipoprotein. Eur J Clin Nutr 2002, 56:72-81.
38. Held H.D., Uhlig S. Mechanisms of endotoxin-induced airway and pulmonary vascular hyperreactivity in mice. Am J Respir Crit Care Med 2000, 162:1547-1552.
39. Fukunaga M., Takahashi K., Badr K.F. Vascular smooth muscle actions and receptor interactions of 8-iso-prostaglandin E2, an E2-isoprostane. Biochem Biophys Res Commun 1993, 195:507-515.
40. Kawikova I., Barnes P.J., Takahashi T., et al. 8-epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am J Respir Crit Care Med 1996, 153:590-596.
41. Okazawa A., Kawikova I., Cui Z.H., et al. 8-epi-PGF(2 alpha) induces airflow obstruction and airway plasma exudation in vivo. Am J Respir Crit Care Med 1997, 155:436-441.
42. Kromer B.M., Tippins J.R. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha. Br J Pharmacol 1996, 119:1276-1280.
43. Mobert J., Becker B.F., Zahler S., et al. Hemodynamic effects of isoprostanes (8-iso-prostaglandin F-2 alpha and E-2) in isolated guinea pig hearts. J Cardiovasc Pharmacol 1997, 29:789-794.
44. Marathe G.K., Harrison K.A., Murphy R.C., et al. Bioactive phospholipid oxidation products. Free Radic Biol Med 2000, 28:1762-1770.
45. Lehr H.A., Weyrich A.S., Saetzler R.K., et al. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest 1997, 99:2358-2364.
46. Halliwell B. Reactive oxygen species in living systems - source, biochemistry, and role in human-disease. Am J Med 1991, 91:S14-S22.
47. Beckman J.S., Beckman T.W., Chen J., et al. Apparent hydroxyl radical production by peroxynitrite - implications for endothelial injury from nitric-oxide and superoxide. Proc Natl Acad Sci U S A 1990, 87:1620-1624.
48. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 1993, 18:195-199.
49. Laskey R.E., Mathews W.R. Nitric oxide inhibits peroxynitrite-induced production of hydroxyeicosatetraenoic acids and F-2-isoprostanes in phosphatidylcholine liposomes. Arch Biochem Biophys 1996, 330:193-198.
50. Spitzer J.A., Zhang P., Mayer A.M.S. Functional-characterization of peripheral circulating and liver recruited neutrophils in endotoxic rats. J Leukoc Biol 1994, 56:166-173.
51. Mates J.M., Perez-Gomez C., Blanca M. Chemical and biological activity of free radical "scavengers" in allergic diseases. Clin Chim Acta 2000, 296:1-15.
52. Lubec B., Hayn M., Denk W., et al. Brain lipid peroxidation and hydroxy radical attack following the intravenous infusion of hydrogen peroxide in an infant. Free Radic Biol Med 1996, 21:219-223.
53. Rahman I., Biswas S.K., Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006, 533:222-239.
54. Mohan I.K., Das U.N. Oxidant stress, anti-oxidants, nitric oxide and essential fatty acids in bronchial asthma. Med Sci Res 1997, 25:307-309.
55. Smith L.J., Shamsuddin M., Sporn P.H.S., et al. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic Biol Med 1997, 22:1301-1307.
56. Nadeem A., Chhabra S.K., Masood A., et al. Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol 2003, 111:72-78.
57. Parker J.C., Townsley M.I. Evaluation of lung injury in rats and mice. Am J Physiol Lung Cell Mol Physiol 2004, 286:L231-L246.